Newswise – Cancer researcher Elana Fertig, Ph.D., has been elected by her peers as a Fellow of the American Institute for Medical and Biological Engineering (AIMBE), a Washington, DC-based nonprofit organization representing the most accomplished individuals in the fields of medical and biological engineering. The College of Fellows comprises the top 2% of medical and biological engineers in the United States.
Fertig is one of 152 new fellows making up the Class of 2022. She is recognized for her outstanding contributions to cancer systems biology and multi-omics.
At Johns Hopkins Kimmel Cancer Center, Fertig has held several leadership positions, including as director of the Quantitative Sciences Division, co-director of the Convergence Institute at the Kimmel Cancer Center, co-director of the Single-Cell Consortium, and associate director of quantitative sciences at the cancer center. She is a Daniel Nathans Science Innovator and Associate Professor of Oncology, Biomedical Engineering, and Applied Mathematics and Statistics.
AIMBE Scholars are regularly recognized for their contributions to teaching, research and innovation. AIMBE Fellows have been awarded the Nobel Prize, Presidential Medal of Science, and Presidential Medal of Technology and Innovation, and many are also members of the National Academy of Engineering, National Academy of Medicine, and the National Academy of Sciences. An official induction ceremony was held at AIMBE’s 2022 annual event on March 25.
Since 1991, the AIMBE College of Fellows has paved the way for technological growth and advancement in the fields of medical and biological engineering. AIMBE Fellows have helped revolutionize medicine and related fields to improve and extend the lives of people all over the world. They have successfully advocated for public policies that have enabled researchers and entrepreneurs to advance the interests of engineers, teachers, scientists, clinicians and, ultimately, patients.
The names of all winners are published here.